查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048343

心血管資訊系統市場－全球產業規模、佔有率、趨勢、機會、預測：按運作模式、系統、區域和競爭對手分類，2021-2031年

Cardiovascular Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mode of Operation (Web based, Cloud based, On site), By System (CVIS, CPACS), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心血管資訊系統 (CVIS) 市場預計將從 2025 年的 15.5 億美元大幅成長至 2031 年的 27.1 億美元，複合年成長率為 9.76%。

CVIS 是專為心臟醫療機構設計的軟體解決方案，旨在透過整合醫學影像、病患記錄和各類報告，管理行政和臨床資料。該市場的成長主要受心臟病發病率上升的驅動，這要求臨床環境中的工作流程管理更加高效，診斷準確性更高。此外，為確保資料連續性和營運效率，與電子健康記錄 (EHR) 整合的需求日益成長，也推動了各類醫療網路對這些平台的採用。然而，市場擴張仍面臨諸多障礙，包括高昂的實施成本以及與複雜資料互通性相關的持續挑戰。即使患者數量不斷增加，這些財務和技術障礙也可能阻礙小規模醫療機構採用 CVIS。高發病率需要全面的數據追蹤，這凸顯了建立強大管理系統的必要性。例如，根據美國心臟協會統計，到 2024 年，美國約有 1.279 億成年人將患有某種形式的心血管疾病。

市場概覽
預測期 2027-2031
市場規模：2025年 15.5億美元
市場規模：2031年 27.1億美元
複合年成長率：2026-2031年 9.76%
成長最快的細分市場 CVIS
最大的市場 北美洲

市場促進因素

心血管疾病盛行率的激增是推動全球加速採用心血管資訊系統的主要動力。隨著心臟病發病率的持續上升，醫療機構越來越需要部署能夠管理龐大而複雜的臨床資料集的集中式數位平台。這些系統對於最佳化工作流程、確保醫療團隊能夠方便地存取關鍵的病患病歷和診斷影像至關重要。死亡率統計數據進一步凸顯了這項迫切需求。根據美國心臟協會於2025年1月發布的《2025年心臟病和中風統計報告》，全球約有1,941年死於心血管疾病。如此巨大的負擔需要擴充性的IT基礎設施設施來支持大量患者管理並改善長期照護效果。同時，人工智慧（AI）和機器學習（ML）的快速融合正在從根本上改變這些資訊系統的技術能力。人工智慧驅動的工具正被整合到心臟軟體中，實現自動影像分析、檢測細微異常以及優先處理急診病例，從而增強臨床決策能力。這項技術進步正獲得醫療專業人士的大力支持，他們認為自動化是應對營運挑戰的有效解決方案。根據飛利浦於2025年8月發布的《2025年未來健康指數：心臟病學概覽》，79%的心臟病護理專業人員認為，人工智慧可以顯著減輕心血管疾病的長期負擔。市場穩定成長的趨勢也體現在監管機構所批准的創新技術的廣泛核准。根據《心血管商業》雜誌2025年7月發表的一篇報導《心臟病學在FDA核准已通過核准心臟病學專用人工智慧演算法用於臨床，這反映出一個由診斷技術進步驅動的強大且不斷擴展的生態系統，這些進步已準備好進行整合。

市場挑戰

除了高昂的實施成本外，複雜的資料互通性問題也是全球心血管資訊系統市場擴張的主要障礙。這些系統需要大量的預付資金，用於許可、必要的硬體基礎設施和全面的員工培訓，這給預算有限的小規模醫療機構和地方診所設置了很高的進入門檻。此外，將這些專業平台與現有的傳統電子健康記錄系統整合，其技術複雜性常常導致資料孤島的出現。這種無縫連接的缺失降低了系統的即時營運價值，並阻礙了醫療機構投資數位轉型，因為他們擔心在沒有效率提升保障的情況下，既有的臨床工作流程會受到干擾。這種財務負擔直接阻礙了市場成長，因為醫療機構通常優先考慮必要的營運成本，而不是技術升級。由於醫院利潤空間有限，資本密集的IT項目往往最先被延後或取消。這種投資意願在近期的產業趨勢中得到了清楚的體現。不斷上漲的成本迫使醫療機構凍結對新技術的投入。根據美國醫院協會 (AHA) 的一項調查，預計到 2025 年，約 94% 的醫療機構管理者將推遲設備升級，以此作為應對財務壓力的策略。這種財務限制極大地限制了循環系統資訊系統的潛在市場，阻礙了其應用，儘管臨床上對更有效的數據管理有明確的需求。

市場趨勢

心血管資訊系統市場的關鍵趨勢是高度重視互通性標準和無縫資料交換。目前，無法跨各種異質平台存取完整的患者病歷是一個重大瓶頸，迫使心血管資訊系統（CVIS）解決方案發展成為一個統一的中心，整合來自電子健康記錄（EHR）和影像歸檔與通訊系統（PACS）的記錄。這種整合的迫切性體現在其能夠解決的營運效率低下問題上。根據飛利浦於2025年8月發布的《2025年未來健康指數：心臟病學概覽》，近80%的心臟護理專業人員表示，由於患者數據不完整或無法訪問，他們浪費了臨床時間。因此，供應商正在優先採用HL7標準，以確保關鍵資訊在臨床實踐中能夠隨時取得。同時，為了顯著提高數據的效用，從自由文本形式的口頭報告向結構化循環系統報告的轉變也在加速進行。與說明報告不同，結構化報告採用標準化模板和獨立的資料字段，便於自動提交至註冊機構，並支援強大的資料探勘功能。這種轉變不僅提高了計費準確性，也顯著減輕了專科醫生的行政負擔，效率提升顯著。根據 AuntMinnie 2025 年 11 月發表的一篇報導《結構化報告工具縮短 CCTA 解讀時間》，一項研究表明，與傳統工作流程相比，使用結構化報告工具可將每個病例的解讀時間縮短 40.2%。這項令人信服的證據促使醫療機構採用結構化模組，旨在減輕醫生的職業倦怠並縮短診斷時間。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心血管資訊系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依營運模式（基於Web、基於雲端、本地部署）
    • 按系統（CVIS、CPACS）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心血管資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心血管資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心血管資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲心血管資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲心血管資訊系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球心血管資訊系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Koninklijke Philips NV
  • General Electric Company
  • Cisco Systems Inc
  • FUJIFILM Medical Systems USA Inc
  • Siemens Healthcare GmbH
  • Cerner Corp
  • Lumedx Corp
  • Digisonics Inc
  • Honeywell International Inc
  • McKesson Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20750

The Global Cardiovascular Information System (CVIS) Market is projected to expand significantly, rising from USD 1.55 Billion in 2025 to USD 2.71 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 9.76%. A CVIS represents a specialized software solution crafted to manage both administrative and clinical data within cardiac care settings through the integration of medical imagery, patient records, and various reports. The market's growth is primarily fueled by the increasing incidence of heart pathologies, which necessitates streamlined workflow management and improved diagnostic precision in clinical environments. Furthermore, the growing demand for electronic health record (EHR) integration to ensure data continuity and operational efficiency supports the broader adoption of these platforms across diverse healthcare networks. However, market expansion faces notable hurdles, including the substantial costs associated with implementation and persistent challenges related to complex data interoperability. These financial and technical barriers can hinder the adoption of CVIS in smaller healthcare facilities, even amidst a rising patient volume. The critical need for robust management systems is underscored by high disease prevalence rates, which demand comprehensive data tracking. For instance, in 2024, approximately 127.9 million adults in the United States were affected by some form of cardiovascular disease, as reported by the American Heart Association.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.55 Billion
Market Size 2031USD 2.71 Billion
CAGR 2026-20319.76%
Fastest Growing SegmentCVIS
Largest MarketNorth America

Market Driver

The escalating prevalence of cardiovascular diseases serves as a primary driver, accelerating the global adoption of cardiovascular information systems. As the incidence of heart pathologies continues to rise, healthcare institutions are increasingly compelled to implement centralized digital platforms capable of managing extensive and intricate clinical datasets. These systems are crucial for optimizing workflows and ensuring that vital patient history and diagnostic imagery are readily accessible to care teams. The urgent need for such systems is further highlighted by mortality statistics; according to the American Heart Association's '2025 Heart Disease and Stroke Statistics' report from January 2025, cardiovascular disease was responsible for approximately 19.41 million global deaths in 2021. This substantial burden mandates scalable IT infrastructure to support high-volume patient management and enhance long-term care outcomes. Concurrently, the rapid integration of artificial intelligence (AI) and machine learning (ML) is fundamentally transforming the technical capabilities of these information systems. AI-driven tools are being embedded into cardiac software to automate image analysis, detect subtle anomalies, and prioritize urgent cases, thereby enhancing clinical decision-making. This technological evolution garners strong support from healthcare professionals who perceive automation as a viable solution to operational challenges. A Philips 'Future Health Index 2025: Cardiology Snapshot' from August 2025 indicated that 79% of cardiac care professionals believe AI can significantly reduce the burden of cardiovascular disease over time. The market's progressive trajectory is also evident in the increasing availability of regulatory-approved innovations. As per a Cardiovascular Business article from July 2025, 'Cardiology still No. 2 in FDA-cleared clinical AI algorithms', the FDA has cleared 116 cardiology-specific AI algorithms for clinical use, reflecting a robust and expanding ecosystem of diagnostic advancements ready for integration.

Market Challenge

The substantial cost of implementation, coupled with intricate data interoperability issues, poses a significant impediment to the expansion of the Global Cardiovascular Information System Market. These systems demand considerable upfront capital for software licensing, necessary hardware infrastructure, and comprehensive staff training, thereby creating a high barrier to entry for smaller healthcare facilities and rural clinics operating with limited budgets. Additionally, the technical complexities involved in integrating these specialized platforms with existing legacy electronic health records frequently lead to the creation of data silos. This absence of seamless connectivity diminishes the immediate operational value of the systems and discourages organizations from investing in digital transformation, as they anticipate potential disruptions to established clinical workflows without guaranteed improvements in efficiency. This financial strain directly hinders market growth, as healthcare providers often prioritize essential operational costs over technological upgrades. In situations where hospitals face constrained margins, capital-intensive IT projects are often among the first to be deferred or cancelled. This reluctance to invest is clearly observed in recent industry trends, where escalating expenses have compelled facilities to freeze spending on new technologies. According to the American Hospital Association in 2025, an estimated 94% of healthcare administrators expected to delay equipment upgrades as a strategy to manage financial pressures. Such fiscal constraints severely limit the accessible market for cardiovascular information systems, preventing widespread adoption despite the evident clinical need for more effective data management.

Market Trends

A defining trend within the cardiovascular information system market is the strong emphasis on interoperability standards and seamless data exchange. The current inability to access complete patient history across various disparate platforms creates critical bottlenecks, prompting CVIS solutions to evolve into unified hubs that consolidate records from both electronic health records (EHRs) and Picture Archiving and Communication Systems (PACS). The urgent necessity of this integration is highlighted by the operational inefficiencies it addresses; a Philips 'Future Health Index 2025: Cardiology Snapshot' from August 2025 revealed that nearly 80% of cardiac care professionals report losing clinical time due to incomplete or inaccessible patient data. Consequently, vendors are prioritizing the adoption of HL7 standards to ensure that vital information is immediately available at the point of care. Simultaneously, there is a growing momentum towards transitioning from free-text dictation to structured cardiovascular reporting to significantly enhance data utility. Unlike narrative reports, structured reporting employs standardized templates with discrete data fields, which facilitates automated registry submission and enables robust data mining capabilities. This shift not only improves billing accuracy but also considerably reduces the administrative workload on specialists. The efficiency gains are substantial; according to an AuntMinnie article from November 2025, 'Structured reporting tool cuts CCTA interpretation time', a study demonstrated that utilizing a structured reporting tool decreased the interpretation time per case by 40.2% compared to traditional workflows. This compelling evidence is driving healthcare facilities to adopt structured modules, aiming to mitigate physician burnout and accelerate diagnostic turnaround times.

Key Market Players

  • Koninklijke Philips N.V.
  • General Electric Company
  • Cisco Systems Inc
  • FUJIFILM Medical Systems USA Inc
  • Siemens Healthcare GmbH
  • Cerner Corp
  • Lumedx Corp
  • Digisonics Inc
  • Honeywell International Inc
  • McKesson Corporation

Report Scope

In this report, the Global Cardiovascular Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiovascular Information System Market, By Mode of Operation

  • Web based
  • Cloud based
  • On site

Cardiovascular Information System Market, By System

  • CVIS
  • CPACS

Cardiovascular Information System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiovascular Information System Market.

Available Customizations:

Global Cardiovascular Information System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiovascular Information System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 5.2.2. By System (CVIS, CPACS)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cardiovascular Information System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Mode of Operation
    • 6.2.2. By System
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiovascular Information System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Mode of Operation
        • 6.3.1.2.2. By System
    • 6.3.2. Canada Cardiovascular Information System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Mode of Operation
        • 6.3.2.2.2. By System
    • 6.3.3. Mexico Cardiovascular Information System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Mode of Operation
        • 6.3.3.2.2. By System

7. Europe Cardiovascular Information System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Mode of Operation
    • 7.2.2. By System
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiovascular Information System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Mode of Operation
        • 7.3.1.2.2. By System
    • 7.3.2. France Cardiovascular Information System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Mode of Operation
        • 7.3.2.2.2. By System
    • 7.3.3. United Kingdom Cardiovascular Information System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Mode of Operation
        • 7.3.3.2.2. By System
    • 7.3.4. Italy Cardiovascular Information System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Mode of Operation
        • 7.3.4.2.2. By System
    • 7.3.5. Spain Cardiovascular Information System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Mode of Operation
        • 7.3.5.2.2. By System

8. Asia Pacific Cardiovascular Information System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Mode of Operation
    • 8.2.2. By System
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiovascular Information System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Mode of Operation
        • 8.3.1.2.2. By System
    • 8.3.2. India Cardiovascular Information System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Mode of Operation
        • 8.3.2.2.2. By System
    • 8.3.3. Japan Cardiovascular Information System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Mode of Operation
        • 8.3.3.2.2. By System
    • 8.3.4. South Korea Cardiovascular Information System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Mode of Operation
        • 8.3.4.2.2. By System
    • 8.3.5. Australia Cardiovascular Information System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Mode of Operation
        • 8.3.5.2.2. By System

9. Middle East & Africa Cardiovascular Information System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Mode of Operation
    • 9.2.2. By System
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiovascular Information System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Mode of Operation
        • 9.3.1.2.2. By System
    • 9.3.2. UAE Cardiovascular Information System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Mode of Operation
        • 9.3.2.2.2. By System
    • 9.3.3. South Africa Cardiovascular Information System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Mode of Operation
        • 9.3.3.2.2. By System

10. South America Cardiovascular Information System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Mode of Operation
    • 10.2.2. By System
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiovascular Information System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Mode of Operation
        • 10.3.1.2.2. By System
    • 10.3.2. Colombia Cardiovascular Information System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Mode of Operation
        • 10.3.2.2.2. By System
    • 10.3.3. Argentina Cardiovascular Information System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Mode of Operation
        • 10.3.3.2.2. By System

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiovascular Information System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Koninklijke Philips N.V.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. General Electric Company
  • 15.3. Cisco Systems Inc
  • 15.4. FUJIFILM Medical Systems USA Inc
  • 15.5. Siemens Healthcare GmbH
  • 15.6. Cerner Corp
  • 15.7. Lumedx Corp
  • 15.8. Digisonics Inc
  • 15.9. Honeywell International Inc
  • 15.10. McKesson Corporation

16. Strategic Recommendations

17. About Us & Disclaimer